Precision medicine is a type of medical therapy and prevention that considers individual differences in genes, environment, and lifestyle, and allows for tailoring based on factors that may influence treatment response. Several genetic and epigenetic risk factors have been linked to late-onset Alzheimer's disease susceptibility (AD). As a result, including genetic risk variables into the AD prevention approach, which has previously mostly focused on universal risk-reduction methods for the whole population rather than personalized, targeted therapies, may be advantageous. This approach to medicine holds a lot of promise for treating the intricacies of people with diverse genetics, lifestyle circumstances, and medical comorbidities who may have different responses to treatment.
Important Alert:
X
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Electrophysiology and alzheimer's pathology: A scoping review on eeg correlations with CSF biomarkers
Charikleia Karastamati, University of Pavia, Italy
Title : The vital role of care homes in supporting individuals with neurological conditions
Akankunda Veronicah, Golden Age Elderly Homes Kampala, Uganda
Title : Semantic-based memory-encoding strategy in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised
Karen P Y Liu, Western Sydney University, Hong Kong